{
  "id": "01b1cad1fd029c1d",
  "title": "Johnson & Johnson Announces U . S . Food and Drug Administration Approves AKEEGA as the First Precision Therapy for BRCA2 - Mutated Metastatic Castration - sensitive Prostate Cancer with 54 % Reduction in Disease Prostate Cancer with 54 % reduction i...",
  "description": "20251213T031500Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/johnson-johnson-announces-u-s-food-and-drug-administration-approves-akeega-as-the-first-precision-ce7d50d8dc89f623",
  "published_at": "20251213T031500Z",
  "fetched_at": "2025-12-14T00:25:01.294421+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/johnson-johnson-announces-u-s-food-and-drug-administration-approves-akeega-as-the-first-precision-ce7d50d8dc89f623",
    "url_mobile": "",
    "title": "Johnson & Johnson Announces U . S . Food and Drug Administration Approves AKEEGA as the First Precision Therapy for BRCA2 - Mutated Metastatic Castration - sensitive Prostate Cancer with 54 % Reduction in Disease Prostate Cancer with 54 % reduction i...",
    "seendate": "20251213T031500Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}